Therapeutic drugs in pregnancy. Caution is the watchword.
Many medical conditions during pregnancy are best treated initially with nonpharmacologic remedies. Before a drug is used during pregnancy, the indications should be clear and the risk-benefit ratio should justify its use. Then, the minimum effective dose should be employed. If possible, therapy should be postponed until after the first trimester.
D000014:Abnormalities, Drug-Induced / Q000209:etiology*; D000700:Analgesics / Q000009:adverse effects; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D000890:Anti-Infective Agents / Q000009:adverse effects; D000927:Anticonvulsants / Q000009:adverse effects; D000932:Antiemetics / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D064420:Drug-Related Side Effects and Adverse Reactions; D045166:Estradiol Congeners / Q000009:adverse effects; D005260:Female; D063647:Fetal Alcohol Spectrum Disorders / Q000209:etiology; D006493:Heparin / Q000009:adverse effects; D006801:Humans; D006939:Hyperemesis Gravidarum / Q000188:drug therapy; D007231:Infant, Newborn; D008094:Lithium / Q000009:adverse effects; D008431:Maternal-Fetal Exchange; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D011372:Progestins / Q000009:adverse effects; D011736:Pyridoxine / Q000627:therapeutic use
D000700:Analgesics; D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D000927:Anticonvulsants; D000932:Antiemetics; D045166:Estradiol Congeners; D011372:Progestins; D006493:Heparin; D008094:Lithium; D011736:Pyridoxine